Inventor · disambiguated record
Reto Naef
Also filed as: NAEF RETO
16 granted patents·9 pending applications·189 citations·filing 1984–2025
91Inventor score
Top patents by PatentIndex Score
25 records- 0189US5177085ADihydro-isoquinoline derivatives, processes for their production, pharmaceutical compositions containing them, and their use in treating asthmaSANDOZ LTD·Filed 1991·Granted Jan 5, 1993·81 cites·10 claims
- 0283US12351585B22-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2023·Granted Jul 8, 2025·0 cites·20 claims
- 0381US5643870AO-acylated cyclosporinsSANDOZ LTD·Filed 1993·Granted Jul 1, 1997·57 cites·11 claims
- 0476US11897890B22-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2021·Granted Feb 13, 2024·0 cites·8 claims
- 0574US2024360136A1Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2023·Application pending·0 cites
- 0671US11905293B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2021·Granted Feb 20, 2024·0 cites·21 claims
- 0771US4980359AIsoquinoline derivatives and their useSANDOZ LTD·Filed 1990·Granted Dec 25, 1990·28 cites·9 claims
- 0871US2025320216A1Phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2025·Application pending·0 cites
- 0966US11242347B22-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2020·Granted Feb 8, 2022·0 cites·20 claims
- 1062US2025161309A1Topical compositions and uses therofTOPADUR PHARMA AG·Filed 2023·Application pending·0 cites
- 1162US2006173181A18-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsBHALAY GURDIP·Filed 2005·Application pending·0 cites
- 1259US7361661B28-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsBHALAY GURDIP·Filed 2006·Granted Apr 22, 2008·0 cites·3 claims
- 1356US10570137B22-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2016·Granted Feb 25, 2020·0 cites·20 claims
- 1456US2007197560A1cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunctionNAEF RETO·Filed 2006·Application pending·0 cites
- 1555US7019136B28-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsNOVARTIS AG·Filed 2004·Granted Mar 28, 2006·0 cites·1 claims
- 1654US11155558B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2018·Granted Oct 26, 2021·0 cites·20 claims
- 1754US5925649AAscomycinsNOVARTIS AG·Filed 1996·Granted Jul 20, 1999·13 cites·15 claims
- 1854US2004214831A1cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunctionNAEF RETO·Filed 2004·Application pending·0 cites
- 1952US2025195522A1Transdermal dosage form, for promoting local blood flow, of dual-acting pde5 inhibitor/organic nitrate esterUIF UNIV INDUSTRY FOUNDATION YONSEI UNIV·Filed 2023·Application pending·0 cites
- 2049US4585892AProcess for the enantioselective production of α-alkylated, acyclic α-aminocarboxylic acidsDEGUSSA·Filed 1984·Granted Apr 29, 1986·3 cites·20 claims
- 2147US2001055570A1cGMP PDE 5 Inhibitors for inhalation in the treatment of sexual dysfunctionFiled 2001·Application pending·0 cites
- 2244US5747506AIsoquinoline compounds, compositions containing them and their pharmaceutical usesCIBA GEIGY AG·Filed 1996·Granted May 5, 1998·5 cites·16 claims
- 2340US12502393B2Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereofTOPADUR PHARMA AG·Filed 2019·Granted Dec 23, 2025·0 cites·18 claims
- 2439US2003171384A18-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitorsFiled 2001·Application pending·0 cites
- 2531US5852005ATetracyclic triterpenesNOVARTIS AG·Filed 1995·Granted Dec 22, 1998·2 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Reto Naef files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →